Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
100%
Cytokine
100%
Tetrahydrobiopterin
100%
Imatinib
100%
Chronic Myeloid Leukemia
100%
Cilostazol
100%
Guanosine Triphosphate Cyclohydrolase I
70%
Edema
50%
Systolic Dysfunction
25%
Tumor Necrosis Factor
20%
Regulator Protein
20%
Disease Course
12%
Leukemia
12%
Nilotinib
12%
Disease Exacerbation
12%
Protein Tyrosine Kinase Inhibitor
12%
Western Blot
10%
High Performance Liquid Chromatography
10%
Intermittent Claudication
10%
Phosphodiesterase III Inhibitor
10%
Biochemistry, Genetics and Molecular Biology
GTP Cyclohydrolase I
100%
Tetrahydrobiopterin
100%
Anabolism
100%
Cytokine
100%
Imatinib
100%
Myeloid
100%
Cyclic Adenosine Monophosphate
57%
Messenger RNA
55%
Tumor Necrosis Factor
28%
Enzyme
14%
Proinflammatory Cytokine
14%
Western Blot
14%
Phosphodiesterase
14%
Protein Expression
14%
High-Performance Liquid Chromatography
14%
Real-Time Polymerase Chain Reaction
14%
Drug Megadose
12%
Tyrosine Kinase Inhibitor
12%
Nilotinib
12%
Keyphrases
Suboptimal Response
100%
BH 4
60%
Left Ventricular Posterior Wall Thickness
25%
End-diastole
25%
Septal Wall Thickness
25%
M-mode Echocardiography
25%
European LeukemiaNet
14%
Early MMR
14%
Blast Phase
14%
GTPCH1
10%